Next frontiers in the genetic epidemiology of Alzheimer's disease

European Journal of Epidemiology

Volumn 27, Issue 11, 2012, Pages 831-836

  Ikram, Mohammad Arfan ^a,b   DeCarli, Charles ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; COPY NUMBER VARIATION; ENDOPHENOTYPE; ETHNICITY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; HERITABILITY; HUMAN; NEUROPATHOLOGY; NOTE; SINGLE NUCLEOTIDE POLYMORPHISM;

ALZHEIMER DISEASE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MOLECULAR EPIDEMIOLOGY;

EID: 84871312225     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-012-9742-2     Document Type: Note

References (54)

1. Thies W, Bleiler L. 2011 Alzheimer's disease facts and figures. Alzheimers Dement. 2011;7(2):208-44.
2. Gatz M, Reynolds CA, Fratiglioni L, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168-74.
3. Bertram L, Tanzi RE. The genetics of Alzheimer's disease. Prog Mol Biol Transl Sci. 2012;107:79-100.
4. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(5):1977-81.
5. Hollingworth P, Harold D, Jones L, et al. Alzheimer's disease genetics: Current knowledge and future challenges. Int J Geriatr Psychiatry. 2011;26(8):793-802.
6. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet. 2012;90(1):7-24.
7. International Hapmap Consortium. The international HapMap project. Nature. 2003;426(6968):789-96.
8. Coon KD, Myers AJ, Craig DW, et al. A high-density wholegenome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry. 2007;68(4):613-8.
9. Grupe A, Abraham R, Li Y, et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genomewide association study of putative functional variants. Hum Mol Genet. 2007;16(8):865-73.
10. Reiman EM, Webster JA, Myers AJ, et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron. 2007; 54(5):713-20.
11. Ikram MA, Liu F, Oostra BA, et al. The GAB2 gene and the risk of Alzheimer's disease: Replication and meta-analysis. Biol Psychiatry. 2009;65(11):995-9.
12. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41(10):1088-93.
13. Lambert JC, Heath S, Even G, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009;41(10):1094-9.
14. Psaty BM, Hofman A. Genome-wide association studies and large-scale collaborations in epidemiology. Eur J Epidemiol. 2010;25(8):525-9.
15. Seshadri S, Fitzpatrick AL, Ikram MA, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832-40.
16. Hollingworth P, Harold D, Sims R, et al.Commonvariants atABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011;43(5):429-35.
17. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/ MS4A6E, CD2AP, CD33 and EPHA1 are associated with lateonset Alzheimer's disease. Nat Genet. 2011;43(5):436-41.
18. Morgan K. The three new pathways leading to Alzheimer's disease. Neuropathol Appl Neurobiol. 2011;37(4):353-7.
19. Verhaaren BF, Vernooij MW, Koudstaal PJ, et al. Alzheimer's disease genes and cognition in the nondemented general population. Biol Psychiatry. 2012. doi: 10.1016/j.biopsych.2012.04.009.
20. Chen LH, Kao PY, Fan YH, et al. Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer's disease in a southern Chinese population. Neurobiol Aging. 2012;33(1): 210.e1-7.
21. Lee JH, Cheng R, Barral S, et al. Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol. 2011;68(3):320-8.
22. Logue MW, Schu M, Vardarajan BN, et al. A comprehensive genetic association study of Alzheimer disease in African Americans. Arch Neurol. 2011;68(12):1569-79.
23. Ferrari R, Hardy J, Momeni P. Frontotemporal dementia: From Mendelian genetics towards genome wide association studies. J Mol Neurosci. 2011;45(3):500-15.
24. Schrijvers EM, Schurmann B, Koudstaal PJ, et al. Genome-wide association study of vascular dementia. Stroke. 2012;43(2):315-9.
25. Van Deerlin VM, Sleiman PM, Martinez-Lage M, et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010;42(3):234-9.
26. Holliday EG, Maguire JM, Evans TJ, et al. Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet. 2012;44(10):1147-51.
27. Traylor M, Farrall M, Holliday EG, et al. Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): A meta-analysis of genome-wide association studies. Lancet Neurol. 2012;11(11):951-62.
28. 1000 Genome Project Consortium. A map of human genome variation from population-scale sequencing. Nature. 2010;467 (7319):1061-73.
29. Holmes D. Mind the IGAP. Lancet Neurol. 2011;10(6):502-3.
30. Kiezun A, Garimella K, Do R, et al. Exome sequencing and the genetic basis of complex traits. Nat Genet. 2012;44(6):623-30.
31. Jonsson T, Atwal JK, Steinberg S, et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature. 2012;488(7409):96-9.
32. Rucker JJ, McGuffin P. Genomic structural variation in psychiatric disorders. Dev Psychopathol. 2012;24(4):1335-44.
33. Brouwers N, Van Cauwenberghe C, Engelborghs S, et al. Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry. 2012;17(2):223-33.
34. Rovelet-Lecrux A, Legallic S, Wallon D, et al. A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease. Eur J Hum Genet. 2012;20(6):613-7.
35. Lambert JC, Grenier-Boley B, Harold D, et al. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry. 2012. doi: 10.1038/mp.2012.14.
36. Broer L, Koudstaal PJ, Amin N, Rivadeneira F, Uitterlinden AG, Hofman A, Oostra BA, Breteler MM, Ikram MA, van Duijn CM. Association of heat shock proteins with Parkinson's disease. Eur J Epidemiol. 2011;26(12):933-5.
37. Hu X, Pickering E, Liu YC, et al. Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease. PLoS ONE. 2011;6(2):e16616.
38. Yang J, Ferreira T, Morris AP, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat Genet. 2012;44(4):369-75, S1-3.
39. McQuillan R, Eklund N, Pirastu N, et al. Evidence of inbreeding depression on human height. PLoS Genet. 2012;8(7):e1002655.
40. Tan Q, Zhao JH, Li S, Kruse TA, Christensen K. Power assessment for genetic association study of human longevity using offspring of long-lived subjects. Eur J Epidemiol. 2010;25(7):501-6.
41. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9(1):119-28.
42. Gallo V, Egger M, McCormack V, Farmer PB, loannidis JP, Kirsch-Volders M, Matullo G, Phillips DH, Schoket B, Stromberg U, Vermeulen R, Wild C, Porta M, Vineis P. STrengthening the reporting of observational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement. Eur J Epidemiol. 2011;26(10):797-810.
43. Ikram MA, van der Lugt A, Niessen WJ, et al. The Rotterdam Scan Study: Design and update up to 2012. Eur J Epidemiol. 2011;26(10):811-24.
44. O'Donnell CJ, Kavousi M, Smith AV, et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation. 2011;124(25):2855-64.
45. Ikram MA, Fornage M, Smith AV, et al. Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet. 2012;44(5):539-44.
46. Taal HR, St Pourcain B, Thiering E, et al. Common variants at 12q15 and 12q24 are associated with infant head circumference. Nat Genet. 2012;44(5):532-8.
47. Bis JC, DeCarli C, Smith AV, et al. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet. 2012;44(5):545-51.
48. Stein JL, Medland SE, Vasquez AA, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet. 2012;44(5):552-61.
49. Fornage M, Debette S, Bis JC, et al. Genome-wide association studies of cerebral white matter lesion burden: The CHARGE consortium. Ann Neurol. 2011;69(6):928-39.
50. Zou F, Carrasquillo MM, Pankratz VS, et al. Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease. Neurology. 2010;74(6):480-6.
51. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage. 2000;11(6 Pt 1):805-21.
52. Hibar DP, Stein JL, Kohannim O, et al. Voxelwise gene-wide association study (vGeneWAS): Multivariate gene-based association testing in 731 elderly subjects. Neuroimage. 2011;56(4): 1875-91.
53. Stein JL, Hua X, Lee S, et al. Voxelwise genome-wide association study (vGWAS). Neuroimage. 2010;53(3):1160-74.
54. Cuenco KT, Lunetta KL, Baldwin CT, et al. Association of distinct variants in SORL1 with cerebrovascular and neurodegenerative changes related to Alzheimer disease. Arch Neurol. 2008;65(12):1640-8.